Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

1.2K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.2K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

4.3K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.3K
Lung Capacity01:47

Lung Capacity

56.7K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.7K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.3K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Pneumothorax-I01:26

Pneumothorax-I

1.8K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.8K
Pleura of the Lungs01:13

Pleura of the Lungs

8.4K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
8.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The relationship between lifestyle factors and outcome of treatment with TNFα inhibitors in axial spondyloarthritis - results from 14 European countries.

BMC rheumatology·2025
Same author

Lung auscultation - today and tomorrow- a narrative review.

Expert review of respiratory medicine·2025
Same author

Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching.

Rheumatology (Oxford, England)·2023
Same author

Corrigendum to 'Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration' [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081].

Seminars in arthritis and rheumatism·2022
Same author

One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.

The Journal of rheumatology·2022
Same author

Respiratory function and CT abnormalities among survivors of COVID-19 pneumonia: a nationwide follow-up study.

BMJ open respiratory research·2022

Related Experiment Video

Updated: Mar 2, 2026

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
07:27

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Published on: January 23, 2026

263

[Vanishing lungs - a case report].

Thorunn Halldora Thordardottir, Arni Jon Geirsson, Sif Hansdottir

    Laeknabladid
    |May 11, 2017
    PubMed
    Summary
    This summary is machine-generated.

    A patient with rheumatoid arthritis developed anti-tumor necrosis factor (TNF) induced lupus and shrinking lung syndrome due to infliximab treatment. Rituximab effectively managed these complications, offering a new therapeutic option.

    Area of Science:

    • Rheumatology
    • Pulmonology
    • Immunology

    Background:

    • Rheumatoid arthritis (RA) management often involves biologic agents like anti-tumor necrosis factor (TNF) therapies.

    More Related Videos

    Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism
    09:31

    Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism

    Published on: February 14, 2022

    2.6K
    Author Spotlight: Standardization and Best Practices for Advancing Lung Imaging Using 129Xe MRI
    09:08

    Author Spotlight: Standardization and Best Practices for Advancing Lung Imaging Using 129Xe MRI

    Published on: November 21, 2023

    1.4K

    Related Experiment Videos

    Last Updated: Mar 2, 2026

    Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
    07:27

    Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

    Published on: January 23, 2026

    263
    Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism
    09:31

    Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism

    Published on: February 14, 2022

    2.6K
    Author Spotlight: Standardization and Best Practices for Advancing Lung Imaging Using 129Xe MRI
    09:08

    Author Spotlight: Standardization and Best Practices for Advancing Lung Imaging Using 129Xe MRI

    Published on: November 21, 2023

    1.4K
  • Adverse pulmonary events, including restrictive lung disease, can occur with anti-TNF agents.
  • Anti-TNF induced lupus is a recognized, albeit uncommon, complication of these therapies.